These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9306348)

  • 1. Steroid withdrawal and donor-specific hyporeactivity after cadaveric renal allotransplantation on maintenance triple therapy.
    Beik AI; Higgins RM; Lam FT; Morris AG
    Nephrol Dial Transplant; 1997 Sep; 12(9):1949-55. PubMed ID: 9306348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of selective decline of donor-reactive IL-2-producing T lymphocytes after renal transplantation.
    Beik AI; Higgins RM; Lam FT; Morris AG
    Transpl Immunol; 1997 Jun; 5(2):89-96. PubMed ID: 9269030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients.
    Oberholzer J; John E; Lumpaopong A; Testa G; Sankary HN; Briars L; Kraft KA; Knight PS; Verghese P; Benedetti E
    Pediatr Transplant; 2005 Aug; 9(4):456-63. PubMed ID: 16048597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced.
    van Besouw NM; van der Mast BJ; de Kuiper P; Smak Gregoor PJ; Vaessen LM; IJzermans JN; van Gelder T; Weimar W
    Transplantation; 2000 Jul; 70(1):136-43. PubMed ID: 10919590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
    Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
    Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal.
    Bouma GJ; Hollander DA; van der Meer-Prins EM; van Bree SP; van Rood JJ; van der Woude FJ; Claas FH
    Transplantation; 1996 Nov; 62(10):1422-9. PubMed ID: 8958267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
    Hussain SM; Marcus RJ; Ko TY; Nashar K; Thai NL; Sureshkumar KK
    Exp Clin Transplant; 2016 Jun; 14(3):287-93. PubMed ID: 27221720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term evaluation of proliferative donor antigen-specific reactivity in cadaveric kidney transplant recipients.
    Böhmig GA; Säemann MD; Bergmann M; Watschinger B; Regele H; Windhager T; Mühlbacher F; Hörl WH; Zlabinger GJ
    Transpl Int; 2000; 13(3):187-93. PubMed ID: 10935701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients.
    Włodarczyk Z; Wałaszewski J; Perner F; Vitko S; Ostrowski M; Bachleda P; Kokot F; Klinger M; Szenohradsky P; Studenik P; Navratil P; Asztalos L; Rutkowski B; Nagy KK; Hickey D
    Ann Transplant; 2002; 7(3):28-31. PubMed ID: 12465429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid withdrawal after renal transplantation: a retrospective cohort study.
    Haller MC; Kammer M; Kainz A; Baer HJ; Heinze G; Oberbauer R
    BMC Med; 2017 Jan; 15(1):8. PubMed ID: 28077142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late Steroid Withdrawal Following AB0-Incompatible Renal Transplantation.
    Bachmann F; Lachmann N; Budde K; Liefeldt L; Halleck F; Naik M; Friedersdorff F; Rudolph B; Wu K; Meyer O; Slowinski T; Waiser J
    Transplant Proc; 2018; 50(1):72-78. PubMed ID: 29407335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation after liver transplantation from the same donor: four cases of successful steroid withdrawal.
    Fuchinoue S; Sawada T; Tsuji K; Kai K; Tojimbara T; Nakajima I; Shiraga H; Ito K; Teraoka S
    Transplantation; 2002 Mar; 73(6):948-52. PubMed ID: 11923698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation.
    Welters MJ; Oei FB; Vaessen LM; Stegmann AP; Bogers AJ; Weimar W
    Clin Exp Immunol; 2001 Jun; 124(3):353-8. PubMed ID: 11472394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
    Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
    Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that human cardiac allograft acceptance is associated with a decrease in donor-reactive helper T lymphocytes.
    DeBruyne LA; Renlund DG; Bishop DK
    Transplantation; 1995 Mar; 59(5):778-83. PubMed ID: 7886807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activity.
    de Haan A; van den Berg AP; Hepkema BG; van Dijk E; Haagsma EB; The TH; Slooff MJ; Lems SP; de Leij LF; Prop J
    Transplantation; 1998 Aug; 66(4):516-22. PubMed ID: 9734497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid avoidance or withdrawal for kidney transplant recipients.
    Pascual J; Zamora J; Galeano C; Royuela A; Quereda C
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005632. PubMed ID: 19160257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.